Compare INUV & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INUV | ELUT |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.2M | 46.5M |
| IPO Year | 1996 | 2020 |
| Metric | INUV | ELUT |
|---|---|---|
| Price | $2.38 | $1.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $12.67 | $6.00 |
| AVG Volume (30 Days) | ★ 370.1K | 174.4K |
| Earning Date | 03-05-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 50.00 | ★ 146.77 |
| EPS | N/A | ★ 0.87 |
| Revenue | ★ $86,209,305.00 | $12,293,000.00 |
| Revenue This Year | $12.82 | N/A |
| Revenue Next Year | $4.23 | $10.83 |
| P/E Ratio | ★ N/A | $1.26 |
| Revenue Growth | ★ 2.88 | N/A |
| 52 Week Low | $0.28 | $0.50 |
| 52 Week High | $6.27 | $2.99 |
| Indicator | INUV | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 47.24 | 55.81 |
| Support Level | $1.67 | $0.89 |
| Resistance Level | $3.64 | $1.39 |
| Average True Range (ATR) | 0.22 | 0.12 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 6.12 | 41.25 |
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.